Share Price and Basic Stock Data
Last Updated: January 22, 2026, 1:16 am
| PEG Ratio | -1.21 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Morarka Finance Ltd operates as a Non-Banking Financial Company (NBFC) and has shown a volatile yet upward trend in its revenue generation over the reported periods. The company’s sales stood at ₹5.86 Cr for the fiscal year ending March 2023, reflecting a notable increase from ₹4.48 Cr in the previous fiscal year. The current trailing twelve months (TTM) revenue is recorded at ₹2.42 Cr, indicating a decline compared to the last fiscal year. Quarterly sales exhibited significant fluctuations, peaking at ₹5.13 Cr in June 2023, followed by a drop to ₹0.01 Cr in March 2023. Despite this inconsistency, the company has demonstrated resilience, with sales reaching ₹1.62 Cr by September 2025. This sporadic revenue pattern may be indicative of operational challenges or market conditions affecting revenue flow. Overall, the revenue trends highlight Morarka’s potential for growth, albeit with an evident need for stable performance in generating consistent sales.
Profitability and Efficiency Metrics
Morarka Finance Ltd has reported a net profit of ₹1.87 Cr, translating to a low return on equity (ROE) of 2.17% and a return on capital employed (ROCE) of 2.46%. The operating profit margin (OPM) stood impressively at 91.98%, reflecting efficient cost management, particularly in the context of its high OPM during the June 2023 quarter at 97.47%. However, the company also recorded a negative operating profit margin of -900% in March 2023, indicating severe inefficiencies during that quarter. The net profit margin has shown a gradual increase, reaching 111.87% for the fiscal year ending March 2025, which is notably high relative to typical sector margins. Morarka’s ability to maintain high operating profit margins while struggling with net profitability underlines the importance of addressing operational challenges to improve overall financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Morarka Finance Ltd reveals a robust position with total assets reported at ₹96.19 Cr as of March 2025, alongside zero borrowings, indicating a debt-free status. This financial structure is complemented by total reserves amounting to ₹90.79 Cr, showcasing significant retained earnings. The price-to-book value (P/BV) ratio stands at a low 0.48x, suggesting that the stock may be undervalued relative to its book value. However, the company’s current ratio is extraordinarily high at 21,693.05, indicating excessive liquidity which could imply inefficiencies in asset utilization. Moreover, the inventory turnover ratio at 11.98 indicates effective inventory management, which is critical for an NBFC. The overall financial ratios depict a company with strong balance sheet fundamentals but necessitate a strategic focus on deploying its excess liquidity to enhance returns on capital.
Shareholding Pattern and Investor Confidence
Morarka Finance Ltd’s shareholding structure is characterized by a significant promoter stake of 66.77%, which remained stable over several quarters, indicating strong control by the founding members. The public shareholding accounts for 33.23%, showing a relatively balanced distribution. The number of shareholders has increased from 2,955 in December 2022 to 4,171 by September 2025, reflecting growing investor interest in the company. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may signal a lack of broader institutional confidence in the stock. This could be a concern for potential investors, as institutional backing often provides a degree of stability and validation in the market. The consistent promoter holding coupled with rising retail participation suggests that Morarka may have a stable investor base, yet the lack of institutional interest remains a notable risk factor.
Outlook, Risks, and Final Insight
Looking ahead, Morarka Finance Ltd faces both opportunities and risks. The company’s ability to sustain high operating profit margins is a strong point, but the variability in revenue and net profit poses significant risks. The historical data indicates that operational efficiency must be prioritized to stabilize earnings and enhance shareholder value. Additionally, the company’s debt-free status provides a cushion against financial distress; however, the high liquidity could be better utilized for growth initiatives. Future performance will heavily depend on management’s strategic decisions regarding capital deployment and operational improvements to mitigate past inefficiencies. If Morarka can achieve a more consistent revenue stream while maintaining its profitability metrics, it may well position itself as a viable player in the NBFC sector. Conversely, failure to address operational challenges could hinder growth and investor confidence, particularly in a competitive financial landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.5 Cr. | 1.45 | 1.81/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.13 Cr. | 0.71 | 7.05/0.62 | 21.0 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 354 Cr. | 54.7 | 125/53.9 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.0 Cr. | 15.3 | 25.9/15.0 | 11.6 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 28.6 Cr. | 63.4 | 146/60.2 | 15.4 | 238 | 1.58 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 27,984.45 Cr | 393.77 | 50.96 | 515.00 | 0.24% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.21 | 0.45 | 0.01 | 5.13 | 0.90 | 0.75 | 0.81 | 0.81 | 1.19 | 0.17 | 0.34 | 0.29 | 1.62 |
| Expenses | 0.06 | 0.11 | 0.10 | 0.13 | 0.08 | 0.13 | 0.12 | 0.13 | 0.11 | 0.15 | 0.16 | 0.14 | 0.13 |
| Operating Profit | 0.15 | 0.34 | -0.09 | 5.00 | 0.82 | 0.62 | 0.69 | 0.68 | 1.08 | 0.02 | 0.18 | 0.15 | 1.49 |
| OPM % | 71.43% | 75.56% | -900.00% | 97.47% | 91.11% | 82.67% | 85.19% | 83.95% | 90.76% | 11.76% | 52.94% | 51.72% | 91.98% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.15 | 0.34 | -0.09 | 5.00 | 0.82 | 0.62 | 0.69 | 1.67 | 1.08 | 0.02 | 0.41 | 0.15 | 1.49 |
| Tax % | 93.33% | 38.24% | 366.67% | 3.80% | 25.61% | 40.32% | 23.19% | 1.80% | 50.00% | -400.00% | -26.83% | 0.00% | 24.83% |
| Net Profit | 0.00 | 0.21 | -0.43 | 4.81 | 0.61 | 0.37 | 0.53 | 1.64 | 0.54 | 0.09 | 0.52 | 0.14 | 1.12 |
| EPS in Rs | 0.00 | 0.47 | -0.96 | 10.68 | 1.35 | 0.82 | 1.18 | 3.64 | 1.20 | 0.20 | 1.16 | 0.31 | 2.49 |
Last Updated: January 6, 2026, 7:35 pm
Below is a detailed analysis of the quarterly data for Morarka Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1.62 Cr.. The value appears strong and on an upward trend. It has increased from 0.29 Cr. (Jun 2025) to 1.62 Cr., marking an increase of 1.33 Cr..
- For Expenses, as of Sep 2025, the value is 0.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.14 Cr. (Jun 2025) to 0.13 Cr., marking a decrease of 0.01 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.49 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Jun 2025) to 1.49 Cr., marking an increase of 1.34 Cr..
- For OPM %, as of Sep 2025, the value is 91.98%. The value appears strong and on an upward trend. It has increased from 51.72% (Jun 2025) to 91.98%, marking an increase of 40.26%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.49 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Jun 2025) to 1.49 Cr., marking an increase of 1.34 Cr..
- For Tax %, as of Sep 2025, the value is 24.83%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Jun 2025) to 24.83%, marking an increase of 24.83%.
- For Net Profit, as of Sep 2025, the value is 1.12 Cr.. The value appears strong and on an upward trend. It has increased from 0.14 Cr. (Jun 2025) to 1.12 Cr., marking an increase of 0.98 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.49. The value appears strong and on an upward trend. It has increased from 0.31 (Jun 2025) to 2.49, marking an increase of 2.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | -0.00 | 0.05 | 0.18 | 0.67 | 2.75 | 0.96 | 5.43 | 1.27 | 4.48 | 5.86 | 7.58 | 2.51 | 2.42 |
| Expenses | 0.32 | 0.22 | 0.33 | 0.45 | 0.37 | 0.42 | 0.45 | 0.36 | 0.42 | 0.38 | 0.46 | 0.56 | 0.58 |
| Operating Profit | -0.32 | -0.17 | -0.15 | 0.22 | 2.38 | 0.54 | 4.98 | 0.91 | 4.06 | 5.48 | 7.12 | 1.95 | 1.84 |
| OPM % | -340.00% | -83.33% | 32.84% | 86.55% | 56.25% | 91.71% | 71.65% | 90.62% | 93.52% | 93.93% | 77.69% | 76.03% | |
| Other Income | 0.11 | 0.16 | 0.17 | 0.05 | -0.00 | -0.00 | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | 1.22 | 0.23 |
| Interest | 0.02 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Depreciation | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Profit before tax | -0.24 | -0.01 | 0.02 | 0.27 | 2.38 | 0.54 | 4.98 | 0.92 | 4.06 | 5.48 | 7.12 | 3.17 | 2.07 |
| Tax % | -8.33% | 300.00% | 50.00% | 29.63% | 1.26% | 12.96% | 0.60% | 25.00% | 8.87% | 14.42% | 11.38% | 11.99% | |
| Net Profit | -0.21 | -0.04 | 0.01 | 0.18 | 2.34 | 0.47 | 4.95 | 0.69 | 3.69 | 4.68 | 6.32 | 2.80 | 1.87 |
| EPS in Rs | -0.47 | -0.09 | 0.02 | 0.40 | 5.20 | 1.04 | 10.99 | 1.53 | 8.20 | 10.40 | 14.04 | 6.22 | 4.16 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | 19.23% | 95.74% | -0.00% | 65.22% | 48.78% | 48.08% | 42.72% | 16.07% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.95% | 125.00% | 1700.00% | 1200.00% | -79.91% | 953.19% | -86.06% | 434.78% | 26.83% | 35.04% | -55.70% |
| Change in YoY Net Profit Growth (%) | 0.00% | 44.05% | 1575.00% | -500.00% | -1279.91% | 1033.11% | -1039.25% | 520.84% | -407.95% | 8.21% | -90.74% |
Morarka Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | -14% |
| 3 Years: | -18% |
| TTM: | -39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | -11% |
| 3 Years: | -9% |
| TTM: | -59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 24% |
| 3 Years: | -12% |
| 1 Year: | -44% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 |
| Reserves | 4.57 | 4.53 | 4.54 | 4.72 | 7.06 | 6.98 | 11.93 | 68.72 | 264.83 | 185.47 | 158.36 | 90.79 | 102.45 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.05 | 0.06 | 0.04 | 0.07 | 0.07 | 0.11 | 0.08 | 0.21 | 0.53 | 0.92 | 1.04 | 0.90 | 1.32 |
| Total Liabilities | 9.12 | 9.09 | 9.08 | 9.29 | 11.63 | 11.59 | 16.51 | 73.43 | 269.86 | 190.89 | 163.90 | 96.19 | 108.27 |
| Fixed Assets | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 8.61 | 8.61 | 8.61 | 8.88 | 11.11 | 11.09 | 13.79 | 72.86 | 269.00 | 189.81 | 162.92 | 95.23 | 107.09 |
| Other Assets | 0.42 | 0.39 | 0.39 | 0.33 | 0.45 | 0.43 | 2.65 | 0.51 | 0.80 | 1.02 | 0.93 | 0.91 | 1.13 |
| Total Assets | 9.12 | 9.09 | 9.08 | 9.29 | 11.63 | 11.59 | 16.51 | 73.43 | 269.86 | 190.89 | 163.90 | 96.19 | 108.27 |
Below is a detailed analysis of the balance sheet data for Morarka Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.50 Cr..
- For Reserves, as of Sep 2025, the value is 102.45 Cr.. The value appears strong and on an upward trend. It has increased from 90.79 Cr. (Mar 2025) to 102.45 Cr., marking an increase of 11.66 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.90 Cr. (Mar 2025) to 1.32 Cr., marking an increase of 0.42 Cr..
- For Total Liabilities, as of Sep 2025, the value is 108.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 96.19 Cr. (Mar 2025) to 108.27 Cr., marking an increase of 12.08 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.05 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 107.09 Cr.. The value appears strong and on an upward trend. It has increased from 95.23 Cr. (Mar 2025) to 107.09 Cr., marking an increase of 11.86 Cr..
- For Other Assets, as of Sep 2025, the value is 1.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.91 Cr. (Mar 2025) to 1.13 Cr., marking an increase of 0.22 Cr..
- For Total Assets, as of Sep 2025, the value is 108.27 Cr.. The value appears strong and on an upward trend. It has increased from 96.19 Cr. (Mar 2025) to 108.27 Cr., marking an increase of 12.08 Cr..
Notably, the Reserves (102.45 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.32 | -0.17 | -0.15 | 0.22 | 2.38 | 0.54 | 4.98 | 0.91 | 4.06 | 5.48 | 7.12 | 1.95 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory Days | 5,840.00 | |||||||||||
| Days Payable | 0.00 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Working Capital Days | 1,095.00 | 344.72 | 92.61 | 43.80 | 91.25 | 16.80 | 57.48 | 13.85 | 10.59 | 13.00 | 16.00 | |
| ROCE % | -2.36% | -0.11% | 0.22% | 2.96% | 22.91% | 4.69% | 35.69% | 2.05% | 2.37% | 2.39% | 4.04% | 2.46% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 6.22 | 14.03 | 10.40 | 8.20 | 1.52 |
| Diluted EPS (Rs.) | 6.22 | 14.03 | 10.40 | 8.20 | 1.52 |
| Cash EPS (Rs.) | 6.22 | 14.04 | 10.40 | 8.21 | 1.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 211.65 | 361.74 | 421.96 | 598.23 | 162.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 211.65 | 361.74 | 421.96 | 598.23 | 162.63 |
| Dividend / Share (Rs.) | 1.00 | 6.00 | 5.00 | 4.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 5.55 | 16.85 | 13.01 | 9.96 | 2.81 |
| PBDIT / Share (Rs.) | 7.05 | 15.82 | 12.16 | 9.01 | 2.05 |
| PBIT / Share (Rs.) | 7.04 | 15.81 | 12.16 | 9.00 | 2.04 |
| PBT / Share (Rs.) | 7.04 | 15.81 | 12.16 | 9.00 | 2.04 |
| Net Profit / Share (Rs.) | 6.21 | 14.03 | 10.40 | 8.20 | 1.52 |
| PBDIT Margin (%) | 126.84 | 93.90 | 93.47 | 90.47 | 72.83 |
| PBIT Margin (%) | 126.73 | 93.86 | 93.42 | 90.40 | 72.56 |
| PBT Margin (%) | 126.73 | 93.86 | 93.42 | 90.40 | 72.56 |
| Net Profit Margin (%) | 111.87 | 83.27 | 79.89 | 82.37 | 54.15 |
| Return on Networth / Equity (%) | 2.93 | 3.87 | 2.46 | 1.37 | 0.93 |
| Return on Capital Employeed (%) | 3.29 | 4.34 | 2.86 | 1.50 | 1.25 |
| Return On Assets (%) | 2.90 | 3.85 | 2.45 | 1.36 | 0.93 |
| Asset Turnover Ratio (%) | 0.01 | 0.04 | 0.02 | 0.02 | 0.02 |
| Current Ratio (X) | 21693.05 | 181301.78 | 135791.86 | 269365.90 | 93947.72 |
| Quick Ratio (X) | 21645.64 | 181069.67 | 135650.00 | 269194.10 | 93743.94 |
| Inventory Turnover Ratio (X) | 11.98 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 96.53 | 35.64 | 38.47 | 12.19 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 96.43 | 35.62 | 38.44 | 12.18 | 0.00 |
| Earning Retention Ratio (%) | 3.47 | 64.36 | 61.53 | 87.81 | 0.00 |
| Cash Earning Retention Ratio (%) | 3.57 | 64.38 | 61.56 | 87.82 | 0.00 |
| Enterprise Value (Cr.) | 45.95 | 66.44 | 47.61 | 46.14 | 14.39 |
| EV / Net Operating Revenue (X) | 18.37 | 8.76 | 8.13 | 10.29 | 11.38 |
| EV / EBITDA (X) | 14.48 | 9.33 | 8.69 | 11.38 | 15.62 |
| MarketCap / Net Operating Revenue (X) | 18.38 | 8.76 | 8.14 | 10.33 | 11.46 |
| Retention Ratios (%) | 3.46 | 64.35 | 61.52 | 87.80 | 0.00 |
| Price / BV (X) | 0.48 | 0.40 | 0.25 | 0.17 | 0.19 |
| Price / Net Operating Revenue (X) | 18.38 | 8.76 | 8.14 | 10.34 | 11.46 |
| EarningsYield | 0.06 | 0.09 | 0.09 | 0.07 | 0.04 |
After reviewing the key financial ratios for Morarka Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.22, marking a decrease of 7.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.22, marking a decrease of 7.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.04 (Mar 24) to 6.22, marking a decrease of 7.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.65. It has decreased from 361.74 (Mar 24) to 211.65, marking a decrease of 150.09.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.65. It has decreased from 361.74 (Mar 24) to 211.65, marking a decrease of 150.09.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 6.00 (Mar 24) to 1.00, marking a decrease of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5.55. It has decreased from 16.85 (Mar 24) to 5.55, marking a decrease of 11.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 15.82 (Mar 24) to 7.05, marking a decrease of 8.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.04. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 7.04, marking a decrease of 8.77.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.04. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 7.04, marking a decrease of 8.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.21. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.21, marking a decrease of 7.82.
- For PBDIT Margin (%), as of Mar 25, the value is 126.84. This value is within the healthy range. It has increased from 93.90 (Mar 24) to 126.84, marking an increase of 32.94.
- For PBIT Margin (%), as of Mar 25, the value is 126.73. This value exceeds the healthy maximum of 20. It has increased from 93.86 (Mar 24) to 126.73, marking an increase of 32.87.
- For PBT Margin (%), as of Mar 25, the value is 126.73. This value is within the healthy range. It has increased from 93.86 (Mar 24) to 126.73, marking an increase of 32.87.
- For Net Profit Margin (%), as of Mar 25, the value is 111.87. This value exceeds the healthy maximum of 10. It has increased from 83.27 (Mar 24) to 111.87, marking an increase of 28.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 15. It has decreased from 3.87 (Mar 24) to 2.93, marking a decrease of 0.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has decreased from 4.34 (Mar 24) to 3.29, marking a decrease of 1.05.
- For Return On Assets (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 5. It has decreased from 3.85 (Mar 24) to 2.90, marking a decrease of 0.95.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 21,693.05. This value exceeds the healthy maximum of 3. It has decreased from 181,301.78 (Mar 24) to 21,693.05, marking a decrease of 159,608.73.
- For Quick Ratio (X), as of Mar 25, the value is 21,645.64. This value exceeds the healthy maximum of 2. It has decreased from 181,069.67 (Mar 24) to 21,645.64, marking a decrease of 159,424.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.98. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 11.98, marking an increase of 11.98.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 96.53. This value exceeds the healthy maximum of 50. It has increased from 35.64 (Mar 24) to 96.53, marking an increase of 60.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 50. It has increased from 35.62 (Mar 24) to 96.43, marking an increase of 60.81.
- For Earning Retention Ratio (%), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 40. It has decreased from 64.36 (Mar 24) to 3.47, marking a decrease of 60.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 40. It has decreased from 64.38 (Mar 24) to 3.57, marking a decrease of 60.81.
- For Enterprise Value (Cr.), as of Mar 25, the value is 45.95. It has decreased from 66.44 (Mar 24) to 45.95, marking a decrease of 20.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 18.37. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.37, marking an increase of 9.61.
- For EV / EBITDA (X), as of Mar 25, the value is 14.48. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 14.48, marking an increase of 5.15.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 18.38. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.38, marking an increase of 9.62.
- For Retention Ratios (%), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 30. It has decreased from 64.35 (Mar 24) to 3.46, marking a decrease of 60.89.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 18.38. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.38, marking an increase of 9.62.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morarka Finance Ltd:
- Net Profit Margin: 111.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.29% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.93% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 21645.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.4 (Industry average Stock P/E: 50.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 111.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 511, Maker Chambers V, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. G R Morarka | Chairman |
| Ms. Priyanka G Morarka | Director |
| Ms. Divya Rao | Director |
| Mr. Arun Kumar Tulsian | Director |
| Ms. Nina Chatrath | Director |
| Ms. K Savitha Rao | Director |
FAQ
What is the intrinsic value of Morarka Finance Ltd?
Morarka Finance Ltd's intrinsic value (as of 22 January 2026) is ₹56.43 which is 10.99% lower the current market price of ₹63.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹28.6 Cr. market cap, FY2025-2026 high/low of ₹146/60.2, reserves of ₹102.45 Cr, and liabilities of ₹108.27 Cr.
What is the Market Cap of Morarka Finance Ltd?
The Market Cap of Morarka Finance Ltd is 28.6 Cr..
What is the current Stock Price of Morarka Finance Ltd as on 22 January 2026?
The current stock price of Morarka Finance Ltd as on 22 January 2026 is ₹63.4.
What is the High / Low of Morarka Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morarka Finance Ltd stocks is ₹146/60.2.
What is the Stock P/E of Morarka Finance Ltd?
The Stock P/E of Morarka Finance Ltd is 15.4.
What is the Book Value of Morarka Finance Ltd?
The Book Value of Morarka Finance Ltd is 238.
What is the Dividend Yield of Morarka Finance Ltd?
The Dividend Yield of Morarka Finance Ltd is 1.58 %.
What is the ROCE of Morarka Finance Ltd?
The ROCE of Morarka Finance Ltd is 2.46 %.
What is the ROE of Morarka Finance Ltd?
The ROE of Morarka Finance Ltd is 2.17 %.
What is the Face Value of Morarka Finance Ltd?
The Face Value of Morarka Finance Ltd is 10.0.